Application no. and date | 03700740.8 (espacenet) (Federated) (European Patent Register), 20030122 | Patent/reg. no. and date | DK/EP 1470107, 20081119 | Publication date | 20041027 | Priority no. and date | US 351384 P, 20020124 | EP pub. no. and date |
EP 1470107 20041027 | Effective date | | Applicant/owner | Merck Canada Inc., 16711 Trans-Canada Highway
Kirkland, Québec H9H 3L1, CA | Applicant ref. no. | | Inventor | LACHANCE, Nicolas, 16711 Trans-Canada Highway
Kirkland, Quebec H9H 3L1, CA, WANG, Zhaoyin, 16711 Trans-Canada Highway
Kirkland, Québec H9H 3L1, CA, BERTHELETTE, Carl, 16711 Trans-Canada Highway
Kirkland, Québec H9H 3L1, CA, LI, Lianhai, 16711 Trans-Canada Highway
Kirkland, Québec H9H 3L1, CA, STURINO, Claudio, 16711 Trans-Canada Highway
Kirkland, Québec H9H 3L1, CA | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | Opponent | | IPC Class | A61K 31/403 (2006.01) , A61P 43/00 (2006.01) , C07D 209/80 (2006.01) , C07D 209/88 (2006.01) | Title | Fluor-substituerede cykloalkanoindoler og anvendelser heraf som prostaglandin D2-receptorantagonister | Int. application no. | CA2003000084 | Int. publication no. | WO2003062200 | Related patent (certificate) | CA 2009 00006 | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|